ask="3.10"
ask_size="200"
average_daily_volume="100627"
bid="3.00"
bid_size="400"
book_value="2.84"
change="+0.10"
change_from_200_day_moving_average="-0.82"
change_from_50_day_moving_average="0.49"
change_from_52_week_high="-3.39"
change_From_52_week_low="1.00"
change_in_percent="+3.45%"
close="3.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.04"
ebitda="-37.85M"
eps_estimate_current_year="-1.83"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="5860000"
high="3.00"
high_52_weeks="6.39"
last_trade_date="2/27/2017"
last_trade_price="3.00"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.90"
low_52_weeks="2.00"
market_capitalization="63.62M"
moving_average_200_day="3.82"
moving_average_50_day="2.51"
name="Strongbridge Biopharma plc"
notes="N/A"
one_year_target_price="14.33"
open="2.95"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-21.37%"
percent_change_from_50_day_moving_average="+19.56%"
percent_change_from_52_week_high="-53.05%"
percent_change_from_52_week_low="+50.00%"
previous_close="2.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.02"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="0.76"
stock_exchange="NMS"
symbol="SBBP"
volume="31600"
weeks_range_52="2.00 - 6.39"
